Mutual of America Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.69M | Sell |
40,008
-1,045
| -3% | -$69.6K | 0.03% | 685 |
|
|
2026
Q1 | $2.58M | Sell |
41,053
-935
| -2% | -$65.1K | 0.03% | 656 |
|
|
2025
Q4 | $2.79M | Sell |
41,988
-619
| -1% | -$40K | 0.03% | 659 |
|
|
2025
Q3 | $2.87M | Sell |
42,607
-6,150
| -13% | -$487K | 0.03% | 668 |
|
|
2025
Q2 | $4.26M | Sell |
48,757
-481
| -1% | -$37.7K | 0.05% | 504 |
|
|
2025
Q1 | $3.36M | Sell |
49,238
-3,692
| -7% | -$301K | 0.04% | 599 |
|
|
2024
Q4 | $4.12M | Sell |
52,930
-4,208
| -7% | -$312K | 0.04% | 548 |
|
|
2024
Q3 | $3.83M | Buy |
57,138
+2,084
| +4% | +$171K | 0.04% | 607 |
|
|
2024
Q2 | $6.24M | Buy |
55,054
+1,229
| +2% | +$155K | 0.07% | 327 |
|
|
2024
Q1 | $7.47M | Sell |
53,825
-1,160
| -2% | -$146K | 0.08% | 273 |
|
|
2023
Q4 | $6.82M | Sell |
54,985
-2,926
| -5% | -$299K | 0.08% | 277 |
|
|
2023
Q3 | $5.4M | Sell |
57,911
-1,477
| -2% | -$166K | 0.07% | 351 |
|
|
2023
Q2 | $7.63M | Buy |
59,388
+572
| +1% | +$69.2K | 0.09% | 236 |
|
|
2023
Q1 | $6.83M | Buy |
58,816
+107
| +0.2% | +$12K | 0.08% | 297 |
|
|
2022
Q4 | $6.65M | Buy |
58,709
+4,241
| +8% | +$466K | 0.08% | 303 |
|
|
2022
Q3 | $4.39M | Buy |
54,468
+848
| +2% | +$71.8K | 0.06% | 471 |
|
|
2022
Q2 | $4M | Buy |
53,620
+1,788
| +3% | +$163K | 0.05% | 547 |
|
|
2022
Q1 | $6.63M | Buy |
51,832
+544
| +1% | +$59.5K | 0.07% | 394 |
|
|
2021
Q4 | $6.88M | Buy |
51,288
+436
| +0.9% | +$62.6K | 0.07% | 389 |
|
|
2021
Q3 | $6.95M | Buy |
50,852
+336
| +0.7% | +$42.4K | 0.07% | 348 |
|
|
2021
Q2 | $5.39M | Buy |
50,516
+916
| +2% | +$88K | 0.05% | 481 |
|
|
2021
Q1 | $4.46M | Buy |
49,600
+1,116
| +2% | +$105K | 0.05% | 581 |
|
|
2020
Q4 | $4.48M | Sell |
48,484
-1,512
| -3% | -$135K | 0.05% | 506 |
|
|
2020
Q3 | $5.15M | Sell |
49,996
-4,168
| -8% | -$435K | 0.07% | 357 |
|
|
2020
Q2 | $5.49M | Buy |
54,164
+51,388
| +1,851% | +$4.6M | 0.08% | 319 |
|
|
2020
Q1 | $187K | Buy |
+2,776
| New | +$173K | ﹤0.01% | 1142 |
|
|
2017
Q3 | – | Sell |
-112,932
| Closed | -$2.06M | – | 1211 |
|
|
2017
Q2 | $2.06M | Sell |
112,932
-3,608
| -3% | -$66.6K | 0.04% | 812 |
|
|
2017
Q1 | $2.47M | Sell |
116,540
-1,108
| -0.9% | -$21.6K | 0.04% | 706 |
|
|
2016
Q4 | $1.76M | Sell |
117,648
-27,904
| -19% | -$494K | 0.03% | 831 |
|
|
2016
Q3 | $3.19M | Hold |
145,552
| – | – | 0.06% | 506 |
|
|
2016
Q2 | $2.89M | Buy |
145,552
+7,068
| +5% | +$120K | 0.06% | 519 |
|
|
2016
Q1 | $2.35M | Sell |
138,484
-800
| -0.6% | -$13.4K | 0.05% | 583 |
|
|
2015
Q4 | $2.85M | Sell |
139,284
-54,216
| -28% | -$1.13M | 0.06% | 470 |
|
|
2015
Q3 | $4.15M | Sell |
193,500
-151,000
| -44% | -$3.37M | 0.1% | 264 |
|
|
2015
Q2 | $6.89M | Sell |
344,500
-44,800
| -12% | -$787K | 0.15% | 122 |
|
|
2015
Q1 | $6.07M | Sell |
389,300
-11,172
| -3% | -$169K | 0.13% | 160 |
|
|
2014
Q4 | $5.51M | Buy |
400,472
+6,252
| +2% | +$76.5K | 0.12% | 184 |
|
|
2014
Q3 | $3.94M | Hold |
394,220
| – | – | 0.09% | 287 |
|
|
2014
Q2 | $3.91M | Sell |
394,220
-187,416
| -32% | -$1.66M | 0.09% | 307 |
|
|
2014
Q1 | $6.01M | Hold |
581,636
| – | – | 0.15% | 135 |
|
|
2013
Q4 | $5.15M | Buy |
581,636
+8,936
| +2% | +$70.7K | 0.13% | 181 |
|
|
2013
Q3 | $4.04M | Buy |
572,700
+14,444
| +3% | +$91.5K | 0.11% | 229 |
|
|
2013
Q2 | $3.13M | Buy |
+558,256
| New | +$2.67M | 0.09% | 298 |
|
Other funds holding DXCM
N
Mutual of America Capital Management's DXCM Position: Q2 2026 in Review
Mutual of America Capital Management reduced its DexCom (DXCM) stake by 2.5% in Q2 2026, selling an estimated $69.6K and leaving 40,008 shares worth $2.69M. The position accounts for 0.03% of the portfolio, ranked #685.
Mutual of America Capital Management first reported a position in DXCM in Q2 2013 and has held it in 43 quarters since. The position peaked at $7.63M in Q2 2023. 585 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Mutual of America Capital Management held 40,008 shares of DexCom worth $2.69M as of Q2 2026.
- Mutual of America Capital Management sold 1,045 DexCom shares in Q2 2026, an estimated $69.6K.
- DexCom made up 0.03% of Mutual of America Capital Management's portfolio in Q2 2026, its #685 holding.
- Mutual of America Capital Management first reported a position in DexCom in Q2 2013 and has held it in 43 quarters since.
- Mutual of America Capital Management's DexCom position peaked at $7.63M in Q2 2023.
- 585 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.